Variant report
Variant | nsv1011399 |
---|---|
Chromosome Location | chr2:35859748-35937722 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:35863760..35866047-chr2:35869717..35871925,2 | MCF-7 | breast: | |
2 | chr2:35887668..35890004-chr2:35892119..35894663,2 | K562 | blood: | |
3 | chr2:35878984..35880554-chr2:35880811..35883619,2 | K562 | blood: | |
4 | chr2:35877173..35880679-chr2:35885712..35889508,3 | MCF-7 | breast: | |
5 | chr2:35877173..35880679-chr2:35885712..35889508,3 | MCF-7 | breast: | |
6 | chr2:35887668..35890004-chr2:35892119..35894663,2 | K562 | blood: | |
7 | chr2:35863760..35866047-chr2:35869717..35871925,2 | MCF-7 | breast: | |
8 | chr2:35878984..35880554-chr2:35880811..35883619,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114323356 | chr2:35860016-35860017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577070476 | chr2:35860020-35860021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190909249 | chr2:35860036-35860037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs180813206 | chr2:35860074-35860075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138679152 | chr2:35860167-35860168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542278349 | chr2:35860171-35860172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185192000 | chr2:35860175-35860176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528158712 | chr2:35860262-35860263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368901267 | chr2:35860368-35860369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190886071 | chr2:35860420-35860421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571348462 | chr2:35860429-35860430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs56181682 | chr2:35860431-35860432 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs565007998 | chr2:35860469-35860470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550851742 | chr2:35860518-35860519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553197301 | chr2:35860545-35860546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183269516 | chr2:35860554-35860555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369233500 | chr2:35860628-35860629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187204983 | chr2:35860661-35860662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs35459711 | chr2:35860681-35860682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536579690 | chr2:35860683-35860684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554653296 | chr2:35860705-35860706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568620191 | chr2:35860737-35860738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79924949 | chr2:35860820-35860821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534032271 | chr2:35860833-35860834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs7571190 | chr2:35860852-35860853 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs191664973 | chr2:35860857-35860858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs142853380 | chr2:35860926-35860927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147434387 | chr2:35860944-35860945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557701136 | chr2:35860971-35860972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531010972 | chr2:35861008-35861009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374663335 | chr2:35861009-35861010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574768824 | chr2:35861076-35861077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs139123559 | chr2:35861079-35861080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs17017132 | chr2:35861090-35861091 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs183123214 | chr2:35861155-35861156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116773947 | chr2:35861208-35861209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564979908 | chr2:35861273-35861274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149943994 | chr2:35861277-35861278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550774761 | chr2:35861353-35861354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs17017134 | chr2:35861398-35861399 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs530010530 | chr2:35861408-35861409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548511457 | chr2:35861447-35861448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144729114 | chr2:35861451-35861452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534209092 | chr2:35861462-35861463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558749740 | chr2:35861469-35861470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs17017136 | chr2:35861472-35861473 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs7560712 | chr2:35861485-35861486 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs556322225 | chr2:35861491-35861492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574731558 | chr2:35861504-35861505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556101950 | chr2:35861522-35861523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:35860000-35891000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:35876000-35876800 | Enhancers | Rectal Mucosa Donor 29 | rectum |
3 | chr2:35876200-35878600 | Enhancers | Fetal Intestine Large | intestine |
4 | chr2:35876600-35877200 | Enhancers | Fetal Intestine Small | intestine |
5 | chr2:35876800-35877200 | Active TSS | Rectal Mucosa Donor 29 | rectum |
6 | chr2:35876800-35877200 | Enhancers | Small Intestine | intestine |
7 | chr2:35877000-35877600 | Enhancers | Liver | Liver |
8 | chr2:35891000-35892000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr2:35901800-35902000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr2:35902000-35902200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr2:35902000-35909000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr2:35902600-35903200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr2:35902800-35903600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr2:35907400-35907600 | Enhancers | Pancreas | Pancrea |
15 | chr2:35908400-35909200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
16 | chr2:35908400-35909200 | Enhancers | Fetal Intestine Large | intestine |
17 | chr2:35909000-35909200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr2:35909200-35910800 | Weak transcription | Fetal Intestine Large | intestine |
19 | chr2:35910000-35910200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr2:35910800-35911000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr2:35910800-35911000 | Enhancers | Fetal Intestine Large | intestine |
22 | chr2:35917800-35918400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
23 | chr2:35922800-35923600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
24 | chr2:35937200-35955200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |